Increased metabolic activity in the heart, skeletal muscle, brain, kidney, adipose tissue and other organs is accompanied by an up to 10-fold rise in blood flow. This is essential in the heart where the fractional extraction of oxygen from blood may be 70% even in the unstimulated state. Isolated hearts exhibit hypoxia-induced vasodilatation, 'reactive' hyperaemia after a period of ischaemia and an autoregulatory response to reduced perfusion pressure, suggesting that factors intrinsic to the heart contribute to metabolic vasodilatation. Considerable evidence has accumulated that adenosine is one endogenous vasodilator substance which fulfils this function. Adenosine concentration is increased in tissues, perfusion media or 'interstitial fluid' during increased energy demand and its concentration correlates closely with blood flow (Berne, 1980) . In addition, dipyridamole, which inhibits adenosine inactivation by preventing its re-uptake into cells, causes a parallel potentiation of interstitial adenosine concentration and blood flow in dogs (Knabb ef a[., 1984) and is a vasodilator in many species, including man. The failure of adenosine receptor antagonists and infused adenosine deaminase to completely prevent metabolic vasodilatation points, however, to the existence of other, as yet largely undefined, mediators.
A major weakness of the adenosine hypothesis of coronary blood-flow regulation is that the biochemical mechanism linking increased energy demand to increased adenosine formation has yet to be defined. In rat polymorphonuclear leucocytes a pathway involving a cytoplasmic 5'-nucleotidase was shown to account for both the magnitude of adenosine formation and its regulation during ATP catabolism (Worku & Newby, 1983) , but the role of this pathway in the heart has not been fully established. It is known that the trigger for adenosine formation in the heart is an imbalance between the rates of ATP synthesis and utilization (Bardenheuer & Schrader, 1986) and that this results in a largefold increase in the cytoplasmic concentration of AMP (Bunger & Soboll, 1986) . There is controversy, however, as to whether this AMP is hydrolysed to adenosine in the cytoplasm or is first exported from the cells by a putative, but uncharacterized, translocase and then hydrolysed by the cell surface ecto-5'-nucleotidase.
Inhibitors of ecto-5'-nucleotidase ([ aB-methylene]ADP or inhibitory antibodies) have been used to test its involvement in adenosine formation. In polymorphonuclear leucocytes, synaptosome beds, lymphocytes, cultured neonatal heart cells and freshly isolated hepatocytes, as well as in isolated perfused rat and guinea-pig hearts, inhibition of 5'-nucleotidase did not reduce the rate of adenosine formation (see Newby er al., 1987 for references). Furthermore, pigeon hearts which contain only 16 k 4 nmol/min per g of ecto-5'-nucleotidase produce adenosine at a rate of 4 10 f 40 nmol/ min per g during ischaemia (Meghji er al., 1988) . In ischaemic guinea-pig hearts (Imai et al., 1987) and in adult rat cardiomyocytes poisoned with dinitrophenol (Bukoski & Sparks, 1986) involvement of the ectoenzyme was implicated, although the possibility that cell disruption was responsible for nucleotide release was not ruled out.
Further evidence for a cytoplasmic pathway of adenosine formation has been obtained using nucleoside transport inhibitors. These increase the tissue content of adenosine in stimulated isolated perfused hearts (Frick & Lowenstein, 1976; Schutz et a[., 1981) and inhibit the release of adenosine from cultured heart cells (Meghji et al., 1985) . The adenosine trapped in hypoxic guinea-pig hearts by nitrobenzylthioinosine was able to react with homocysteine to form S-adenylhomocysteine and was therefore in the cytoplasmic compartment of (presumably) the cardiac myocytes.
The identity and properties of the cytoplasmic 5'-nucleotidase responsible for adenosine formation needs to be further defined. A soluble 5'-nucleotidase purified from rat (Itoh et a[., 1986) or chicken (Itoh & Oka, 1985) heart was closely similar to that previously purified by the same workers from mammalian and avian liver. The enzyme is structurally and immunologically (Worku & Newby, 1983) distinct from the ectoenzyme and is activated rather than inhibited by nucleotide di-and tri-phosphates. The enzyme is further characterized by a neutral pH optimum, a preference for IMP (K, = 0.2 mM) over AMP (K, = 2-10 mM) and by inhibition by PI and 5'-deoxy-5'-isobutylthioadenosine, but not by p-nitrophenylphosphate (Newby, 1988) . The 5'-nucleotidase activity in pigeon ventricle homogenates was characterized (Newby et al., 1987) under conditions (4.8 mM-ATP, 2.8 mM-ADP, 0.66 mM-AMP, 1 mM-free Mg2+, pH 6.9) mimicking those in the cytoplasm of ischaemic hearts. The activity towards AMP was 4500 k 400 nmol/min per g ( n = 25) which was more than enough to explain ischaemia-induced adenosine formation. The activity towards 3 mM-IMP was 5 9 0 f 4 0 nmol/min per g ( n = 6 ) .
The activity was found in the soluble fraction in KCIcontaining buffer, but was associated with the particulate fraction after homogenization in sucrose-containing buffer (Newby, 1988) . On subcellular fractionation the enzyme partitioned between the soluble and low speed (nuclear) fractions (data not shown). The activity had a pH optimum close to pH 7.0 ( n = 2) and a K , for AMP of 4.6-5.2 mM ( n = 2). The activity towards AMP was reduced by 10 mM of ( n = 6 ) and of p-nitrophenylphosphate to 21 f 2% ( n = 5).
The activity was not inhibited by 10 mM-ribose phosphate or B-glycerophosphate nor by 4 m~-5'-deoxy-5'-isobutylthioadenosine ( n = 6).
An activity was detected in homogenates of rat hearts under the same conditions, but was much lower (172 f 17 nmol/min per g, n = 6 ) . This activity was not inhibited by 10 mM-B-glycerophosphate or by 4 m~-5'-deoxy-IMP to 16-22%, of dIMP to 22-24%, of GMP to 50-68%, ~t CMP to 45-57%, Of UMP to 36-42%, Of PI to 88f3'/0
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The inhibition of the pigeon ventricle AMPase by other nucleoside monophosphates (with specificity for the base moeity), but not by ribose phosphate or B-glycerophosphate, indicates the presence of a 5'-nucleotidase. its preference for AMP, resistance to inhibition by P, and 5'-deoxy-5'-isobutylthioadenosine and its inhibition by p-nitrophenylphosphate suggest that it is distinct from the previously purified cytosolic 5'-nucleotidase. Its high activity towards AMP suggests that it is responsible for ischaemiainduced adenosine production. The similar activity discovered in rat heart is too small to account for all of the absolute rate of ischaemia-induced adenosine formation (470 k 70 nmol/min per g) observed in this tissue (Meghji et ul., 1988) . It may, however, contribute to this rate.
In conclusion, there is extensive evidence for adenosine production in response to net ATP breakdown by a cytoplasmic pathway not involving ecto-.5'-nucleotidase. A soluble AMP S'-nucleotidase abundant in pigeon ventricle, but also found in rat ventricle may be responsible for the formation of that adenosine which mediates metabolic vasodilatation.
Introduction
Although there have been clear indications for almost 50 years that purine nucleotides, particularly ATP and ADP, have powerful cardiovascular actions (see Gordon, 1986; Hellewell & Pearson, 1987 and references therein) and might be important regulators of vessel tone in pathological situations such as traumatic shock (Green & Stoner, 1950) , it is only recently that the pharmacological basis for distinct actions of purine nucleotides from those of adenosine has been studied. This has been due largely to the innovative studies by Burnstock and colleagues who have provided much of the evidence that ATP and ADP act at separate receptors ( Pz purinoceptors, whereas adenosine acts at P, purinoceptors) to achieve these effects (reviewed in Burnstock & Kennedy, 1985a,b) . This article briefly summarizes current knowledge of purine-nucleotide-mediated regulation of vessel tone.
Soiirces of circicluting nucleotides
ATP is present in the cytoplasm of almost all cell types at concentrations of a few millimolar. Thus, any stimulus that can release ATP, either selectively or non-selectively, from cells will lead to the transient presence of extracellular nucleotide in concentrations locally reaching hundreds of micromolar, which is more than sufficient to evoke P,-purinoceptor-mediated responses whose threshold is typically at = 1 ,MUM. Clearly, large-scale mechanical trauma provides a pathological mechanism for such nucleotide release. Recent careful studies also demonstrated that ATP levels in blood emerging from a defined micro-incision into a blood vessel reach 20 ,UM in a few minutes (Born & Kratzer, 1984) . These authors deduced that the early rise in ATP (to --2 ,UM) was a consequence of damage to cells of the vessel wall, while the later rise was due to local platelet aggregation. This latter process provides an important source of extracellular nucleotides: platelet stimulation leads to secretion of nucleotides from granules (where ATP and ADP are stored at concentrations of = 1 M ) into plasma.
ATP can be detected in effluent perfusate when isolated organs are exercised or made hypoxic (Paddle & Burnstock, 1974; Forrester, 198 1) or following nerve stimulation (Fredholm et al., 1982) or infusion of other stimuli (Schrader et at., 1982) . Brief treatment of cultured endothelial cells with proteinases can lead to selective release of bioactive levels of nucleotides without permanent damage to the cells (Pearson & Gordon, 1979) . Although the levels of ATP and ADP detected in such experiments are often lower than those of adenosine, it is reasonable to suppose that they were substantially higher where they were generated, since levels are regulated by ectonucleotidases, as described below.
Ectonucleotidases
The evidence cited above indicates that biologically active levels of extracellular nucleotides can be generated locally by a variety of pathophysiological mechanisms. Efficient inactivation processes must exist for any potential active mediator, and for ATP and ADP, which are powerful modulators of platelet activation in addition to their effects on vessel tone, inactivation is due to catabolism by ectonucleotidases at the luminal surface of endothelium. The first indications of this came when it was noted that the half-life of ATP
